Supplementary Figure S3 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Rodriguez-Berriguete G., Ranzani M., Prevo R., Puliyadi R., Machado N., Bolland HR., Millar V., Ebner D., Boursier M., Cerutti A., Cicconi A., Galbiati A., Grande D., Grinkevich V., Majithiya JB., Piscitello D., Rajendra E., Stockley ML., Boulton SJ., Hammond EM., Heald RA., Smith GCM., Robinson HMR., Higgins GS.
Accompanies Figure 2 (ART558 treatment leads to increased residual IR-induced DNA damage foci)